OpenCodelists
Welcome to OpenCodelists, created by OpenSAFELY for creating and sharing codelists.
Anybody can also use this tool to create and share codelists. To get started, take a look at the documentation or watch the videos.
If you would like to publish codelists on behalf of an organisation, please get in touch.
Below, you'll find all the codelists we have used in OpenSAFELY research to date.
All codelists
- Opioid-containing medicines (inhalation- excluding drugs for substance misuse) - Pseudo BNF BNF
-
All opioid-containing products which are given via inhaled route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
Published by OpenSAFELY - Opioid-containing medicines (inhalation- excluding drugs for substance misuse) - dm+d dm+d
-
All opioid-containing products which are given via inhaled route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
Published by OpenSAFELY - Opioid-containing medicines (oral - excluding drugs for substance misuse) - Pseudo BNF BNF
-
All opioid-containing products which are given via oral route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
Published by OpenSAFELY - Opioid-containing medicines (oral - excluding drugs for substance misuse) - dm+d dm+d
-
All opioid-containing products which are given via oral route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
Published by OpenSAFELY - Opioid-containing medicines (parenteral- excluding drugs for substance misuse) - Pseudo BNF BNF
-
All opioid-containing products which are given via parenteral route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
Published by OpenSAFELY - Opioid-containing medicines (parenteral- excluding drugs for substance misuse) - dm+d dm+d
-
All opioid-containing products which are given via parenteral route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
Published by OpenSAFELY - Opioid-containing medicines (rectal - excluding drugs for substance misuse) - Pseudo BNF BNF
-
All opioid-containing products which are given via rectal route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
Published by OpenSAFELY - Opioid-containing medicines (rectal - excluding drugs for substance misuse) - dm+d dm+d
-
All opioid-containing products which are given via rectal route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
Published by OpenSAFELY - Opioid-containing medicines (transdermal- excluding drugs for substance misuse) - Pseudo BNF BNF
-
All opioid-containing products which are given via transdermal route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
Published by OpenSAFELY - Opioid-containing medicines (transdermal- excluding drugs for substance misuse) - dm+d dm+d
-
All opioid-containing products which are given via transdermal route of administration, EXCLUDING products listed in section 4.10 (substance misuse) of the legacy BNF code structure. Drugs outside of this, but not included in "opioid analgesics" in the BNF ARE included (e.g. co-codamol, alfentanil)
Published by OpenSAFELY - Oral Anticoagulant review SNOMED CT
-
Taken from the
ORANTICOAGREVW_COD
refset published by NHSD.Published by NHSD Primary Care Domain Refsets - Oral Steroid Drugs (PRA) (DM+D) dm+d
-
Taken from the Oral Steroid Drugs tab of the Population Risk COVID-19 Treatments code list v1.3, published by NHS Digital, 2021-12-13.
Published by NHS Digital - Oral anticoagulant contraindications (expiring) SNOMED CT
-
Taken from the
TXORANTICOAG_COD
refset published by NHSD.Published by NHSD Primary Care Domain Refsets - Oral anticoagulant contraindications (persisting) SNOMED CT
-
Taken from the
XORANTICOAG_COD
refset published by NHSD.Published by NHSD Primary Care Domain Refsets - Oral anticoagulant prophylaxis codes SNOMED CT
-
Taken from the
ORANTICOAG_COD
refset published by NHSD.Published by NHSD Primary Care Domain Refsets